Capabilities
Antitrust/Competition

Life Sciences and Medical Devices

Arnold & Porter's Antitrust/Competition practice enjoys an international reputation for effective antitrust and competition advocacy in the life sciences, pharmaceutical, and medical device sectors in the US and EU. We coordinate multidisciplinary teams of lawyers, economists, and industry experts to craft creative business-responsive solutions that address our clients' local and international regulatory and litigation needs. Our team has handled a significant number of engagements representing life sciences clients.

Experience

Hikma Pharmaceuticals Acquisition of generic drug business
Obtained antitrust clearance for the company’s US$2 billion acquisition of the Roxane Laboratories generic drug business
Hikma Pharmaceuticals Acquisition of generic injectable drug business
Obtained antitrust clearance for its US$300 million acquisition of the Bedford generic injectable drug business from Boehringer Ingelheim.
Aduro Biotech Inc. Collaboration with Novartis
Represented client in negotiation of collaboration with Novartis.
General Electric Company PharmaRx Class Action
Secured dismissal with prejudice of complaint in putative class action alleging anticompetitive conduct relating to radiopharmaceutical distribution and successfully defended judgment on appeal.
Boston Scientific Corporation Acquisition of American Medical Systems urology portfolio
Obtained antitrust clearance for the company’s US$1.6 billion acquisition of American Medical Systems’ urology portfolio from Endo. 
More
Overview

Email Disclaimer